Skip to main content
SpringerLink
Log in

Cardiogenic Shock Complicating ST-Segment Elevation Acute Coronary Syndrome

  • Chapter
Cardiogenic Shock

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 164 Accesses

Abstract

Severe left ventricular dysfunction sufficient to cause cardiogenic shock can result from each of the acute coronary syndromes, including ST-elevation myocardial infarction, non—ST-elevation myocardial infarction, and unstable angina without infarction (1). This chapter will focus on shock resulting from ST-elevation myocardial infarction. In part, because the definition of cardiogenic shock and the study population with acute coronary syndromes have varied in different series, the reported incidence of cardiogenic shock complicating acute coronary syndromes has also varied. In two large, international series of patients receiving thrombolytic therapy for acute myocardial infarction, the reported incidence of shock differed between countries, being greatest in the United States; whether this was the result of differing adherence of the diagnosis, different vigilance for identifying diagnostic criteria, the result of different therapies used in the countries, or true geographic variability, is unknown (2,3).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996; 335: 775–782.

    Article  Google Scholar 

  2. Holmes DR Jr, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. J Am Coll Cardiol 1995; 26: 668–674.

    Article  PubMed  Google Scholar 

  3. Hasdai D, Holmes DR Jr, Topol EJ, et al. Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase: results from GUSTO III. Eur Heart J 1999; 20: 128–135.

    Article  PubMed  CAS  Google Scholar 

  4. Holmes DR Jr, Berger PB, Hochman JS, et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 1999; 100: 2067–2073.

    Article  PubMed  Google Scholar 

  5. AIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988; 1: 545–549.

    Google Scholar 

  6. Wilcox RG, von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 1988; 1: 525–530.

    Article  Google Scholar 

  7. Barbash IM, Hasdai D, Behar S, et al. Usefulness of pre-versus postadmission cardiogenic shock during acute myocardial infarction in predicting survival. Am J Cardiol 2001; 87: 1200–1203.

    Article  PubMed  CAS  Google Scholar 

  8. Hasdai D, Califf RM, Thompson TD, et al. Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 2000; 35: 136–143.

    Article  PubMed  CAS  Google Scholar 

  9. Holmes DR Jr, Calif RM, Van de Werf F, et al. Differences in countries’ use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet 1997; 349: 75–78.

    Article  PubMed  Google Scholar 

  10. Connors AF Jr, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 1996; 276: 889–897.

    Article  PubMed  Google Scholar 

  11. Bengtson JR, Kaplan AJ, Pieper KS et al. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol 1992; 20: 1482–1489.

    Article  PubMed  CAS  Google Scholar 

  12. Gruppo Italiano per lo Studio della Streptochinasi nell’ Infarto Miocardico. Effectiveness of intravenous thrombolytic therapy in acute myocardial infarction. Lancet 1986; 1: 397–401.

    Google Scholar 

  13. Jacobs AK, French JK, Col J, et al. Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol 2000; 36: 1091–1096.

    Article  PubMed  CAS  Google Scholar 

  14. Hochman JS, Sleeper LA, White HD, et al. One-year survival following early revascularization for cardiogenic shock. JAMA 2001; 285: 190–192.

    Article  PubMed  CAS  Google Scholar 

  15. Prewitt RM, Gu S, Garber PJ, Ducas J. Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator. J Am Coll Cardiol 1992; 20: 1626–1633.

    Article  PubMed  CAS  Google Scholar 

  16. Prewitt RM, Gu S, Schick U, Ducas J. Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent. J Am Coll Cardiol 1994; 23: 794–798.

    Article  PubMed  CAS  Google Scholar 

  17. Kern MJ, Aguirre F, Bach R, Donohue T, Siegel R, Segal J. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation 1993; 87: 500–511.

    Article  PubMed  CAS  Google Scholar 

  18. Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon pump counter-pulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol 2000; 36: 1123–1129.

    Article  PubMed  CAS  Google Scholar 

  19. Berger PB, Holmes DR Jr, Stebbins AL, Bates ER, Califf RM, Topol EJ. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) Trial: an observational study. Circulation 1997; 96: 122–127.

    Article  PubMed  CAS  Google Scholar 

  20. Stomel RJ, Rasak M, Bates ER. Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital. Chest 1994; 105: 997–1002.

    Article  PubMed  CAS  Google Scholar 

  21. Anderson RD, Ohman EM, Holmes DR Jr., et al. Use of intra-aortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. J Am Coll Cardiol 1997; 30: 708–715.

    Article  PubMed  CAS  Google Scholar 

  22. Dunkman WB, Leinbach RC, Buckley MJ, et al. Clinical and hemodynamic results of intraaortic balloon pumping and surgery for cardiogenic shock. Circulation 1972; 46: 465–477.

    Article  PubMed  CAS  Google Scholar 

  23. Bardet J, Masquet C, Khan JC, et al. Clinical and hemodynamic results of intra-aortic balloon counter-pulsation and surgery for cardiogenic shock. Am Heart J 1977; 93: 280–288.

    Article  PubMed  CAS  Google Scholar 

  24. DeWood MA, Notske RN, Hensley GR, et al. Intraaortic balloon counterpulsation with and without reperfusion of myocardial infarction shock. Circulation 1980; 61: 1105–1112.

    Article  PubMed  CAS  Google Scholar 

  25. Subramanian VA, Roberts Ai, Zema MJ, et al. Cardiogenic shock following acute myocardial infarction: late functional results after emergency cardiac surgery. NY State J Med 1980; 80: 947–952.

    CAS  Google Scholar 

  26. Berger PB, Tuttle RH, Holmes DR Jr, et al. One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: Results from the GUSTO-I trial. Circulation 1999; 99: 873–878.

    Article  PubMed  CAS  Google Scholar 

  27. Hochman JS, Boland J, Sleeper LA, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Circulation 1995; 91: 873–881.

    Article  PubMed  CAS  Google Scholar 

  28. Urban P, Stauffer JC, Bleed D, et al. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction: the (Swiss) Multicenter trial of Angioplasty for SHock–(S)MASH. Eur Heart J 1999; 96: 1030–1038.

    Article  Google Scholar 

  29. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999; 341: 625–634.

    Article  PubMed  CAS  Google Scholar 

  30. Hochman JS, Sleeper LA, Webb JG, et al. Effects of early revascularization for cardiogenic shock on 1 year mortality: The SHOCK trial results. Circulation 1999; 100 (suppl I): 1–369.

    Article  Google Scholar 

  31. Hasdai D, Harrington RA, Hochman JS, et al. Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol 2000; 36: 685–692.

    Article  PubMed  CAS  Google Scholar 

  32. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999; 340: 1162–1168.

    Article  PubMed  CAS  Google Scholar 

  33. Hasdai D, Holmes DR Jr, Califf RM, et al. Cardiogenic shock complicating acute myocardial infarction: predictors of mortality. Am Heart J 1999; 138: 21–31.

    Article  PubMed  CAS  Google Scholar 

  34. Starling MR, Dell’Italia LJ, Chandhuri TK, Boros BL, O’Rourke RA. First transit and equilibrium radionuclide angiography in patients with inferior transmural myocardial infarction: criteria for the diagnosis of associated hemodynamically significant right ventricular infarction. J Am Coll Cardiol 1984; 4: 923–930.

    Article  PubMed  CAS  Google Scholar 

  35. Sharpe ND, Botvinick EH, Shames DM, et al. The noninvasive diagnosis of right ventricular infarction. Circulation 1978; 57: 483–490.

    Article  PubMed  CAS  Google Scholar 

  36. Shah PK, Maddahi J, Berman DS, Pichler M, Swan HJC: Scintigraphically detected predominant right ventricular dysfunction in acute myocardial infarction: clinical and hemodynamic correlates and implications for therapy and prognosis. J Am Coll Cardiol 1985; 6: 1264–1272.

    Article  PubMed  CAS  Google Scholar 

  37. Dell’Italia LJ, Starling MR, O’Rourke RA: Physical examination for exclusion of hemodynamically important right ventricular infarction. Ann Intern Med 1983; 99: 608–611.

    Article  PubMed  Google Scholar 

  38. Erhardt LR, Sjogren A, Wahlberg I. Simple right-sided precordial lead in the diagnosis of right ventricular involvement in inferior myocardial infarction. Am Heart J 1976; 91: 571–576.

    Article  PubMed  CAS  Google Scholar 

  39. Croft CH, Nicod P, Corbett JR, et al. Detection of acute right ventricular infarction by right precordial electrocardiography. Am J Cardiol 1982; 50: 421–427.

    Article  PubMed  CAS  Google Scholar 

  40. Kalan JM, Gertz SD, Kragel A, Berger PB, Roberts WC, Ryan TJ. Effects of tissue plasminogen activator therapy on right ventricular infarction studied at necropsy as part of the Thrombolysis in Myocardial Infarction (TIMI) study. Int J Cardiol 1993; 38: 151–158.

    Article  PubMed  CAS  Google Scholar 

  41. Berger PB, Ruocco NA, Ryan TJ, et al. Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the Thrombolysis in Myocardial Infarction (TIMI II) Trial). Am J Cardiol 1993; 71: 1148–1152.

    Article  PubMed  CAS  Google Scholar 

  42. Berger PB, Ryan TJ. Inferior infarction: high risk-subgroups. Circulation 1990; 81: 401–411.

    Article  PubMed  CAS  Google Scholar 

  43. Pfisterer M, Emmenegger H, Soler M, Burkhart F. Prognostic significance of right ventricular ejection fraction for persistent complex ventricular arrhythmias and/or sudden cardiac death after first myocardial infarction: relation to infarct location, size, and left ventricular function. Eur Heart J 1986; 7: 289–298.

    PubMed  CAS  Google Scholar 

  44. Gadsboll N, Hoilund-Carlsen PF, Madsen EB, et al. Right and left ventricular ejection fractions: relation to one-year prognosis in acute myocardial infarction. Eur Heart J 1987; 8: 1201–1209.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Peter B. Berger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Hasdai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Tel-Aviv University, Tel Aviv, Israel

    David Hasdai MD  & Alexander Battler MD  & 

  2. Department of Cardiology, Rabin Medical Center, Petah-Tikva, Israel

    Alexander Battler MD

  3. Internal Medicine and Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA

    Peter B. Berger MD  & David R. Holmes Jr. MD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Berger, P.B., Hasdai, D. (2002). Cardiogenic Shock Complicating ST-Segment Elevation Acute Coronary Syndrome. In: Hasdai, D., Berger, P.B., Battler, A., Holmes, D.R. (eds) Cardiogenic Shock. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-154-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-154-1_4

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-312-1

  • Online ISBN: 978-1-59259-154-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation